Variant report
Variant | nsv518963 |
---|---|
Chromosome Location | chr2:49038154-49052293 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:48996460..48999048-chr2:49041792..49043593,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4256004 | chr2:49038154-49038155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181329023 | chr2:49038192-49038193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs35625756 | chr2:49038244-49038245 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs78640999 | chr2:49038257-49038258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541700637 | chr2:49038272-49038273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs149939755 | chr2:49038329-49038330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530202097 | chr2:49038355-49038356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs372747758 | chr2:49038363-49038364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563761525 | chr2:49038372-49038373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531033738 | chr2:49038430-49038431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552259770 | chr2:49038467-49038468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148219932 | chr2:49038488-49038489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs372199006 | chr2:49038490-49038491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144132103 | chr2:49038539-49038540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185986188 | chr2:49038577-49038578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528486484 | chr2:49038582-49038583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs78484326 | chr2:49038664-49038665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148702504 | chr2:49038670-49038671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12999088 | chr2:49038671-49038672 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs188990917 | chr2:49038672-49038673 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554746534 | chr2:49038695-49038696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569790941 | chr2:49038736-49038737 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537103724 | chr2:49038745-49038746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs558689461 | chr2:49038789-49038790 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576881204 | chr2:49038791-49038792 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12998973 | chr2:49038803-49038804 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs553040362 | chr2:49038900-49038901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575057770 | chr2:49038923-49038924 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs76859786 | chr2:49038924-49038925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563900205 | chr2:49038936-49038937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575749654 | chr2:49038976-49038977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551204649 | chr2:49038997-49038998 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566547951 | chr2:49039022-49039023 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533571815 | chr2:49039071-49039072 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554940589 | chr2:49039099-49039100 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377493135 | chr2:49039118-49039119 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545862721 | chr2:49039121-49039122 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564254232 | chr2:49039138-49039139 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181864420 | chr2:49039140-49039141 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs369983208 | chr2:49039146-49039147 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs55930451 | chr2:49039237-49039238 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs529992632 | chr2:49039238-49039239 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569861746 | chr2:49039253-49039254 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78192079 | chr2:49039259-49039260 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537266748 | chr2:49039296-49039297 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552268920 | chr2:49039309-49039310 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570548689 | chr2:49039311-49039312 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187361204 | chr2:49039312-49039313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552932720 | chr2:49039313-49039314 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12713016 | chr2:49039343-49039344 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 22522925 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:48994600-49080200 | Weak transcription | Stomach Smooth Muscle | stomach |
2 | chr2:49032800-49039000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr2:49037200-49045400 | Weak transcription | Ovary | ovary |
4 | chr2:49038600-49039800 | Enhancers | Fetal Intestine Large | intestine |
5 | chr2:49039000-49040000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr2:49039200-49039800 | Enhancers | H9 Cell Line | embryonic stem cell |
7 | chr2:49039200-49039800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr2:49039200-49040000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr2:49039200-49040400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr2:49039400-49039600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr2:49039800-49043600 | Weak transcription | Fetal Intestine Large | intestine |
12 | chr2:49040200-49040400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr2:49040400-49041200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
14 | chr2:49041200-49041400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr2:49042400-49042600 | Enhancers | Fetal Intestine Small | intestine |
16 | chr2:49042600-49043400 | Weak transcription | Fetal Intestine Small | intestine |
17 | chr2:49043400-49045600 | Enhancers | Fetal Intestine Small | intestine |
18 | chr2:49043600-49047000 | Enhancers | Fetal Intestine Large | intestine |
19 | chr2:49045400-49045800 | Enhancers | Ovary | ovary |
20 | chr2:49045800-49046000 | Weak transcription | Ovary | ovary |
21 | chr2:49046000-49046600 | Enhancers | Ovary | ovary |
22 | chr2:49046200-49047000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
23 | chr2:49046200-49047800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
24 | chr2:49046600-49053200 | Weak transcription | Ovary | ovary |